Next Article in Journal
PTEN Inhibition in Human Disease Therapy
Next Article in Special Issue
Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals
Previous Article in Journal
Peptides as Potential Therapeutics for Alzheimer’s Disease
Previous Article in Special Issue
Amikacin: Uses, Resistance, and Prospects for Inhibition
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 23
Issue 2
10.3390/molecules23020284
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors

by
Sandra G. Zárate
1,
M. Luisa De la Cruz Claure
2,
Raúl Benito-Arenas
3,
Julia Revuelta
3,
Andrés G. Santana
3,* and
Agatha Bastida
3,*
1
Facultad de Tecnología-Carrera de Ingeniería Química, Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca, Regimiento Campos 180, Casilla 60-B, Sucre, Bolivia
2
Facultad de Ciencias Químico Farmacéuticas y Bioquímicas, Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca, Dalence 51, Casilla 497, Sucre, Bolivia
3
Departmento de Química Bio-Orgánica, Instituto de Química Orgánica General (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Molecules 2018, 23(2), 284; https://doi.org/10.3390/molecules23020284
Submission received: 7 November 2017 / Revised: 12 January 2018 / Accepted: 26 January 2018 / Published: 30 January 2018
(This article belongs to the Special Issue Recent Development on the New Applications of Aminoglycosides)
Browse Figures
Versions Notes

Abstract

Resistance to aminoglycoside antibiotics has had a profound impact on clinical practice. Despite their powerful bactericidal activity, aminoglycosides were one of the first groups of antibiotics to meet the challenge of resistance. The most prevalent source of clinically relevant resistance against these therapeutics is conferred by the enzymatic modification of the antibiotic. Therefore, a deeper knowledge of the aminoglycoside-modifying enzymes and their interactions with the antibiotics and solvent is of paramount importance in order to facilitate the design of more effective and potent inhibitors and/or novel semisynthetic aminoglycosides that are not susceptible to modifying enzymes.
Keywords: antibiotic resistance; combination therapy; bi-substrate inhibitors; decoy acceptors antibiotic resistance; combination therapy; bi-substrate inhibitors; decoy acceptors

Share and Cite

MDPI and ACS Style

Zárate, S.G.; De la Cruz Claure, M.L.; Benito-Arenas, R.; Revuelta, J.; Santana, A.G.; Bastida, A. Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors. Molecules 2018, 23, 284. https://doi.org/10.3390/molecules23020284

AMA Style

Zárate SG, De la Cruz Claure ML, Benito-Arenas R, Revuelta J, Santana AG, Bastida A. Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors. Molecules. 2018; 23(2):284. https://doi.org/10.3390/molecules23020284

Chicago/Turabian Style

Zárate, Sandra G., M. Luisa De la Cruz Claure, Raúl Benito-Arenas, Julia Revuelta, Andrés G. Santana, and Agatha Bastida. 2018. "Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors" Molecules 23, no. 2: 284. https://doi.org/10.3390/molecules23020284

APA Style

Zárate, S. G., De la Cruz Claure, M. L., Benito-Arenas, R., Revuelta, J., Santana, A. G., & Bastida, A. (2018). Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors. Molecules, 23(2), 284. https://doi.org/10.3390/molecules23020284

Article Metrics

Back to TopTop